Crossmark

Anti-GAD antibody-negative, anti-IA2 antibody-positive slowly progressive insulin-dependent diabetes mellitus and Graves’ disease preceded by childhood-onset minimal change nephrotic syndrome: a case report

Crossref DOI link: https://doi.org/10.1007/s13340-024-00787-6

Published Online: 2025-01-13

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kodama, Yoshimi https://orcid.org/0009-0009-6149-3439
Okabe, Taijiro

Sasaki, Shuji

Yokomizo, Hisashi

Sakamoto, Ryuichi

Niimi, Kazuhiko

Ogawa, Yoshihiro
License Information

Text and Data Mining valid from 2025-01-13

Version of Record valid from 2025-01-13
More Information

Article History

Received: 21 June 2024

Accepted: 18 December 2024

First Online: 13 January 2025

Declarations

:

: RS received honoraria/lecture fees from Eli Lilly Japan K.K., Nippon Boehringer Ingelheim Co. Ltd., Novo Nordisk Pharma Ltd., Daiichi Sankyo Co. Ltd., and Mitsubishi Tanabe Pharma Co.. All other authors declare no conflict of interest.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

Document is current

Any future updates will be listed below